Medical Health Cluster

vaccine

Psilocybin Effective Up to 12 Weeks in Severe Depression

NEW ORLEANS – A single dose of a synthetic formulation of psilocybin provides rapid improvement in treatment-resistant depression, with benefits sustained for up to 12 weeks, according to results from the largest randomized controlled study of psilocybin to date. Dr Guy Goodwin “This is easily the largest study of a psychedelic drug employing […]

Read More

Novavax Hopes Its COVID Shot Wins Over FDA, Vaccine Holdouts

 Americans may soon get a new COVID-19 vaccine option — shots made with a more tried-and-true technology than today’s versions. The big question: Why should they care? After long delays, the Food and Drug Administration is expected to decide within weeks whether to authorize Novavax’s vaccine. It’s late in the […]

Read More

Emergence and Evolution of H5N1 Bird Flu

Emergence and Evolution of H5N1 Bird Flu (Text Version) [illustration of different bird types] 1996-1997 H5N1 bird flu viruses first detected In 1996, highly pathogenic avian influenza H5N1 virus is first identified in domestic waterfowl in Southern China. The virus is named A/goose/Guangdong/1/1996. In 1997, H5N1 poultry outbreaks happen in […]

Read More

Flu Vaccine Linked to Lower Risk for Stroke: INTERSTROKE

Having had a recent acute febrile illness was associated with an increased risk for ischemic stroke, whereas having received an influenza vaccination was associated with a reduced risk for stroke in a large new case–control study. “While influenza vaccination is a cost-effective method to prevent influenza, it is also an […]

Read More

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Abstract BACKGROUND With large waves of infection driven by the B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), alongside evidence of waning immunity after the booster dose of coronavirus disease 2019 (Covid-19) vaccine, several countries have begun giving at-risk persons a fourth vaccine dose. METHODS To evaluate […]

Read More

Testing and Treating Can Help Normalize COVID and Daily Life

“Test and treat” is a critical strategy for people and society returning to more normal activities. Now that the early responses to the COVID-19 pandemic have — sort of — been met (ie, minimizing infection, spread, illness, and death with masks, testing, contact tracing, social distancing, and vaccines), we are […]

Read More

About 19% of COVID-19 Headaches Become Chronic

Approximately 1 in 5 patients who presented with headache during the acute phase of COVID-19 developed chronic daily headache, according to a study published in the journal Cephalalgia. The greater the headache’s intensity during the acute phase, the greater the likelihood that it would persist. The research, carried out by members of the Headache Study Group […]

Read More